Companies: 10,795·Total market cap: $144.5T
GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGSNASDAQHealthcare● Active
$55.65
+$3.85(+7.43%)
Market Cap$1.7B
P/E Ratio
52W High$170.87
52W Low$32.21
Overview

GeneDx Holdings Corp.(WGS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · WGS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.43B$0.31B$0.20B$0.23B$0.21B
Cost of Revenue$0.13B$0.11B$0.11B$0.26B$0.23B
Gross Profit$0.30B$0.19B$0.09B($0.03B)($0.02B)
Gross Margin %(computed)69.74%63.64%44.43%-11.40%-7.82%
Operating Expenses
R&D Expenses$0.07B$0.05B$0.06B$0.09B$0.11B
G&A Expenses$0.15B$0.10B$0.13B$0.22B$0.21B
Total Operating Expenses$0.31B$0.22B$0.27B$0.64B$0.43B
Operating Income($0.01B)($0.02B)($0.18B)($0.67B)($0.45B)
Operating Margin %(computed)-2.76%-7.60%-89.15%-284.48%-210.25%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.02B)($0.05B)($0.18B)($0.60B)($0.25B)
Income Tax Expense($0.00B)($0.00B)($0.00B)($0.05B)$0.00B
Net Income($0.02B)($0.05B)($0.18B)($0.55B)($0.25B)
Net Margin %(computed)-4.92%-17.12%-86.77%-233.91%-115.64%
Per Share & EBITDA
EPS (Basic)$-0.73$-1.94$-7.23$-53.63$-74.93
Wtd Avg Shares0.03B0.03B0.02B0.01B0.00B
EBITDA$0.01B($0.00B)($0.14B)($0.40B)($0.22B)
EBITDA Margin %(computed)1.55%-0.41%-67.37%-169.67%-104.03%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解GeneDx Holdings Corp.

关于GeneDx Holdings Corp.(WGS)损益表

GeneDx Holdings Corp.(WGS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,WGS实现营收$0.43B,毛利润$0.30B(毛利率69.74%),净利润($0.02B)(净利率-4.92%)。

常见问题

WGS · 4 问

GeneDx Holdings Corp.(WGS)2025财年营收为$0.43B,同比up40.0%。

WGS revenueWGS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09